ZyVersa Therapeutics, Inc. 8-K

What Happened

• ZyVersa Therapeutics, Inc. (ZVSA) announced in an SEC Form 8-K (filed July 16, 2026) that it ceased trading on the OTCQB® Venture Market and commenced trading on the OTC Pink Limited Market effective July 16, 2026. The filing is reported under Item 8.01 (Other Events).

Key Details

• Effective date: July 16, 2026.
• Change: Stopped trading on OTCQB® Venture Market; began trading on OTC Pink Limited Market.
• Filing: Reported in an 8-K under Item 8.01 (Other Events).

Why It Matters

• Trading venue change can affect liquidity and visibility: OTC Pink is generally less actively traded and has fewer listing standards than OTCQB, which can lead to lower trading volume and wider bid-ask spreads.
• Disclosure and investor access: Investors should be aware the company is now quoted on the OTC Pink Limited Market when looking up quotes, trading information, or regulatory disclosure.
• No financial results, management changes, or other corporate actions were reported in this 8-K; the filing only discloses the market transfer.